FDA approves AbbVie’s Skyrizi to treat Crohn’s Disease in adults

By PBR Staff Writer

The US Food and Drug Administration (FDA) has approved AbbVie’s approved Skyrizi (risankizumab-rzaa) for the treatment of Crohn's disease (CD) in adults.